SCHEMBL23840360

SCHEMBL23840360

COc1ncc(NC(=O)c2snnc2C2CC2)cc1S(=O)(=O)Nc1c(C)cccc1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3C2G O75747 3/20 0.38
PIK3CA P42336 2/20 0.38
PIK3CG P48736 2/20 0.38
CRACR2A Q9BSW2 4/20 0.38
MAPT P10636 3/20 0.38
LMNA P02545 2/20 0.38
TP53 P04637 2/20 0.38
ABCC8 Q09428 1/20 0.37
KCNJ11 Q14654 1/20 0.37
PIK3C3 Q8NEB9 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
DUSP3 P51452 1/20 0.36
PTPN5 P54829 1/20 0.36
PTPN11 Q06124 1/20 0.36
EDNRB P24530 1/20 0.35
EDNRA P25101 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23840333 0.88 LMNA (0.47) PIK3C2GPIK3CAPIK3CGCRACR2AMAPT
SCHEMBL23840437 0.86 PIK3CA (0.40) PIK3C2GPIK3CAPIK3CGMAPTLMNA
SCHEMBL23840570 0.83 PIK3C3 (0.39) PIK3C2GPIK3CAPIK3CGMAPTLMNA
SCHEMBL23840653 0.82 PIK3C3 (0.39) PIK3C2GPIK3CAPIK3CGMAPTLMNA
SCHEMBL23840651 0.79 THRB (0.53) MAPTLMNATP53PIK3C3MEN1
SCHEMBL23840553 0.79 NAMPT (0.49) PIK3C2GPIK3CAPIK3CGCRACR2AMAPT
SCHEMBL23840657 0.79 PIK3C3 (0.37) PIK3C2GPIK3CAPIK3CGMAPTLMNA
SCHEMBL23840576 0.79 MAPT (0.42) MAPTLMNAPIK3C3MEN1KMT2A
SCHEMBL23840364 0.78 GRM4 (0.40) PIK3C2GPIK3CAPIK3CGMAPTLMNA
SCHEMBL25485494 0.78 KCNK3 (0.52) MAPTLMNAMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159509-A1 PYRIDINESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-05-25 US disclosed
WO-2021188907-A1 PYRIDINESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2021-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159509-A1 PYRIDINESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF TRAP1, PINK1, PPM1D PIK3C2G 2403/4885PIK3CA 422/4885PIK3CG 1166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.